The Inducible Nitric Oxide Synthase Pathway Promotes Osteoclastogenesis under Hypoxic Culture Conditions.
Animals
Bone Resorption
/ genetics
Cell Differentiation
/ drug effects
Cell Hypoxia
/ drug effects
Cells, Cultured
Enzyme Induction
/ drug effects
Hypoxia
/ genetics
Male
Mice
Mice, Inbred C57BL
Nitric Oxide Synthase Type II
/ antagonists & inhibitors
Osteoclasts
/ drug effects
Osteogenesis
/ drug effects
Oxygen
/ pharmacology
Signal Transduction
/ drug effects
omega-N-Methylarginine
/ pharmacology
Journal
The American journal of pathology
ISSN: 1525-2191
Titre abrégé: Am J Pathol
Pays: United States
ID NLM: 0370502
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
received:
19
04
2021
revised:
09
08
2021
accepted:
31
08
2021
pubmed:
25
9
2021
medline:
15
12
2021
entrez:
24
9
2021
Statut:
ppublish
Résumé
Bone homeostasis depends on the balance between bone resorption by osteoclasts (OCs) and bone formation by osteoblasts. Bone resorption can become excessive under various pathologic conditions, including rheumatoid arthritis. Previous studies have shown that OC formation is promoted under hypoxia. However, the precise mechanisms behind OC formation under hypoxia have not been elucidated. The present study investigated the role of inducible nitric oxide synthase (iNOS) in OC differentiation under hypoxia. Primary bone marrow cells obtained from mice were stimulated with receptor activator of NF-κB ligand and macrophage colony-stimulating factor to induce OC differentiation. The number of OCs increased in culture under hypoxia (oxygen concentration, 5%) compared with that under normoxia (oxygen concentration, 20%). iNOS gene and protein expression increased in culture under hypoxia. Addition of an iNOS inhibitor under hypoxic conditions suppressed osteoclastogenesis. Addition of a nitric oxide donor to the normoxic culture promoted osteoclastogenesis. Furthermore, insulin-like growth factor 2 expression was significantly altered in both iNOS inhibition experiments and nitric oxide donor experiments. These data might provide clues to therapies for excessive osteoclastogenesis under several hypoxic pathologic conditions, including rheumatoid arthritis.
Identifiants
pubmed: 34560064
pii: S0002-9440(21)00390-4
doi: 10.1016/j.ajpath.2021.08.014
pii:
doi:
Substances chimiques
omega-N-Methylarginine
27JT06E6GR
Nitric Oxide Synthase Type II
EC 1.14.13.39
Nos2 protein, mouse
EC 1.14.13.39
Oxygen
S88TT14065
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2072-2079Informations de copyright
Copyright © 2021 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.